跳到正文
WHO 药品预认证与检查动态·· 2026-08-27AI 评分46

QCIL 的蒿甲醚/苯芴醇片获 WHO 预认证

QCIL’s Artemether/Lumefantrine tablet prequalified

AI 导读

WHO 预认证部门将 Quality Chemical Industries Limited(QCIL,乌干达)的 MA211 蒿甲醚/苯芴醇 20mg/120mg 片列入预认证清单。该产品按技术转移产品评估,参照 Cipla 的 MA064 产品。WHO 预认证表示支持加强本地制药生产能力的举措,并欢迎企业间的技术转移安排及类似合作。

正文

News

27 August, 2026 - 00:12 (CEST)

Announcement

WHO Prequalification Unit (PQT) added the below new product to its prequalified list:

  • MA211 Artemether/Lumefantrine 20mg/120mg tablet – Quality Chemical Industries Limited (QCIL) – Uganda

    The product was assessed as a technology transfer product, with reference to Cipla’s MA064 product.
    WHO Prequalification remains committed to supporting initiatives that strengthen local pharmaceutical manufacturing capacity and welcomes technology transfer arrangements and similar collaborative partnerships between companies.
     

来源:WHO 药品预认证与检查动态 · extranet.who.int